Latest industry research report on Alzheimers Disease Therapeutics Market. Alzheimers is a neurodegenerative disorder that mostly occurs with aging and is a leading cause of dementia. The global Alzheimers disease market has observed tremendous growth in the recent years, owing to the high prevalence of Alzheimers disease and increased life expectancy of population.
Alzheimers is one of the leading causes of death in the United States, with more than 5 million Americans diagnosed with this dreaded disease, in year 2014. Presently, very few therapeutic alternatives are available in the market and none of them provide a complete cure for this condition. This indicates an impending market need that would provide lucrative growth opportunities to the industry players.
Get Free Sample Report Of Alzheimers Disease Therapeutics Market @ http://www.marketresearchstore.com/report/world-alzheimers-disease-therapeutics-and-diagnostics-market-71670#RequestSample
Rising old age population and higher incidences of neurodegenerative diseases are two significant factors that supplement the market growth. Moreover, increasing R&D investment and a large number of drugs in the pipeline are further expected to fuel the market growth. However, high cost of treatment and lack of transparent reimbursements are likely to curtail the market growth.
Alzheimers patients are generally diagnosed in the late stage, mostly due to delayed appearance of symptoms. Hence, developing the early diagnostic devices would be a significant challenge for the diagnostic device makers.
The research collaborations and new product launches are some of the key strategies adopted by leading industry players. For instance, Actavis plc in collaboration with Adamas Pharmaceuticals Inc. recently announced the US FDA approval of Namzaric, a fixed-dose combination of memantine and donepezil. The drug is expected to be launched in the first half of year 2015.
Do Inquiry To Buy Report Of Alzheimers Disease Therapeutics Market @ http://www.marketresearchstore.com/report/world-alzheimers-disease-therapeutics-and-diagnostics-market-71670#InquiryForBuying
The Alzheimers Disease Therapeutics and Diagnostics Market is segmented below:
Alzheimers Disease Therapeutics and Diagnostics Market By Therapeutics
- Marketed Drugs
- Cholinesterase inhibitors
- NMDA receptor antagonist
- Pipeline Drugs
Alzheimers Disease Therapeutic and Diagnostic Market By Diagnostics
- Lumbar puncture test
- Computed tomography (CT) scan
- Magnetic resonance imaging (MRI)
- Electroencephalography (EEG)
- Positron emission tomography (PET) scan
Alzheimers Disease Therapeutics and Diagnostics Market By Geography
- North America
About Market research Store
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651